Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
All content for TGen Talks is the property of TGen and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
Episode 83: Discovering a Future in Science — The Helios Scholars at TGen Program
TGen Talks
17 minutes 23 seconds
4 months ago
Episode 83: Discovering a Future in Science — The Helios Scholars at TGen Program
Summers at TGen offer a unique opportunity for students to dive into the world of biomedical research. The Helios Scholars Program at TGen actively engages student interns in real-world science and administrative functions, as they gain practical experience and contribute to ongoing projects. Join host Karie Dozer as Helios Scholar Audra Welch shares her unfiltered experience in the intensive eight-week program. Discover how this Northern Arizona University biology and Spanish major is diving headfirst into biomedical research, specifically exploring how age influences the brain's response to sepsis. Audra candidly discusses the thrill and challenge of wet lab work, building on the extensive research of her Ph.D. mentor, and the unique experience of preparing for a research symposium presentation. She also reflects on her journey from environmental engineering to medical microbiology and shares the surprising inspiration she found in an American surgeon and medical researcher Dr. Charles Drew. Whether you are an aspiring scientist, or simply curious about the next generation of researchers behind the biomedical advances of the future, Audra’s insights reveal the supportive and welcoming environment at TGen, where learning and discovery drive the science behind the breakthroughs.
TGen Talks
Episode 87 of TGen Talks features Dr. Haiyong Han, who dives into his latest work on one of the deadliest of cancers: pancreatic cancer.
He breaks down why this disease is so hard to catch early, how it can grow silently for years before symptoms appear, and why identifying true positives in general population is such a big challenge.
Dr. Han also shares promising progress toward a new non-invasive screening test that could one day enable earlier detection of pancreatic cancer. The goal? To turn this deadly disease into a more manageable condition, and give patients real hope for the future.
As we recognize Pancreatic Cancer Awareness Month in November, this episode emphasizes the urgent need for improved diagnostic methods, more effective treatments, and continued research to change the outcome for patients everywhere.
